Deborah (Deb) Miller, Ph.D., J.D., joined Nuvalent as Chief Legal Officer in June 2021 and is responsible for legal and human resources. She brings more than 20 years of senior leadership and global legal expertise across the entire pharmaceutical lifecycle from early discovery though litigation.
Prior to joining Nuvalent, she most recently served as Senior Vice President, Deputy General Counsel and Chief IP Counsel for Sumitomo Dainippon Pharma America (SDPA), a shared services company supporting affiliates of the Sumitomo Dainippon Pharma Group including Sunovion Pharmaceuticals Inc. and SDP Oncology. At SDPA, she led global IP strategy, IP diligence, as well as various contract dispute matters and business development transactions and was instrumental in building and enforcing global IP portfolios for over 30 oncologic, neurologic, psychiatric, and respiratory products, including LATUDA®, KYNMOBI®, APTIOM®, and LONHALA® MAGNAIR®.
Earlier in her career, Deb served as Deputy General Counsel and Chief Patent Counsel at Infinity Pharmaceuticals where she was responsible for developing the IP strategy of various oncology products and helped secure multiple strategic partnerships. In addition, she served as Corporate Counsel at Sepracor (now Sunovion) where she managed the litigation of LUNESTA® and developed the IP for various CNS and respiratory products. She began her legal career in private practice at Nutter McClennen & Fish.
Deb earned her Bachelor’s degree in chemistry from Swarthmore College, Master’s in Medical Sciences from Harvard Medical School, Ph.D. in biological chemistry and molecular pharmacology from Harvard University, and J.D. from Suffolk University Law School.
What is Deborah Ann Miller's net worth?
The estimated net worth of Deborah Ann Miller is at least $2.23 million as of April 4th, 2024. Dr. Miller owns 33,300 shares of Nuvalent stock worth more than $2,226,438 as of April 27th. This net worth evaluation does not reflect any other assets that Dr. Miller may own. Additionally, Dr. Miller receives a salary of $595,960.00 as insider at Nuvalent. Learn More about Deborah Ann Miller's net worth.
How old is Deborah Ann Miller?
Dr. Miller is currently 48 years old. There are 4 older executives and no younger executives at Nuvalent. The oldest executive at Nuvalent is Prof. Matthew D. Shair Ph.D., Founder, Head of Scientific Advisory Board & Director, who is 55 years old. Learn More on Deborah Ann Miller's age.
What is Deborah Ann Miller's salary?
As the insider of Nuvalent, Inc., Dr. Miller earns $595,960.00 per year. There are 3 executives that earn more than Dr. Miller. The highest earning executive at Nuvalent is Dr. James R. Porter Ph.D., CEO, President & Director, who commands a salary of $998,020.00 per year. Learn More on Deborah Ann Miller's salary.
How do I contact Deborah Ann Miller?
Has Deborah Ann Miller been buying or selling shares of Nuvalent?
During the last quarter, Deborah Ann Miller has sold $220,800.00 of Nuvalent stock. Most recently, Deborah Ann Miller sold 3,000 shares of the business's stock in a transaction on Thursday, April 4th. The shares were sold at an average price of $73.60, for a transaction totalling $220,800.00. Following the completion of the sale, the insider now directly owns 33,300 shares of the company's stock, valued at $2,450,880. Learn More on Deborah Ann Miller's trading history.
Who are Nuvalent's active insiders?
Are insiders buying or selling shares of Nuvalent?
During the last year, insiders at the sold shares 35 times. They sold a total of 1,466,651 shares worth more than $103,203,548.94. The most recent insider tranaction occured on April, 22nd when Director Matthew Shair sold 37,500 shares worth more than $2,386,875.00. Insiders at Nuvalent own 14.8% of the company.
Learn More about insider trades at Nuvalent. Information on this page was last updated on 4/22/2024.
